After adjustment for the TNF-α or IL-17 levels, however, the CD4 AI levels were still higher in the COPD groups, with both p-values being smaller than 0.01 (Figure 3C and D). This evidence concerns the gene CD4 and chronic obstructive pulmonary disease.